Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Regenxbio (RGNX) Total Non-Current Liabilities (2018 - 2025)

Historic Total Non-Current Liabilities for Regenxbio (RGNX) over the last 8 years, with Q3 2025 value amounting to $363.1 million.

  • Regenxbio's Total Non-Current Liabilities rose 9880.15% to $363.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $363.1 million, marking a year-over-year increase of 9880.15%. This contributed to the annual value of $202.7 million for FY2024, which is 733.28% down from last year.
  • Latest data reveals that Regenxbio reported Total Non-Current Liabilities of $363.1 million as of Q3 2025, which was up 9880.15% from $366.7 million recorded in Q2 2025.
  • Regenxbio's 5-year Total Non-Current Liabilities high stood at $366.7 million for Q2 2025, and its period low was $163.2 million during Q1 2021.
  • In the last 5 years, Regenxbio's Total Non-Current Liabilities had a median value of $205.3 million in 2023 and averaged $214.6 million.
  • As far as peak fluctuations go, Regenxbio's Total Non-Current Liabilities surged by 27858.6% in 2021, and later plummeted by 1605.96% in 2024.
  • Regenxbio's Total Non-Current Liabilities (Quarter) stood at $178.3 million in 2021, then rose by 0.68% to $179.5 million in 2022, then rose by 21.88% to $218.7 million in 2023, then fell by 7.33% to $202.7 million in 2024, then soared by 79.13% to $363.1 million in 2025.
  • Its Total Non-Current Liabilities stands at $363.1 million for Q3 2025, versus $366.7 million for Q2 2025 and $205.6 million for Q1 2025.